UPMC Shadyside participates in a number of research studies, including cancer and nursing research.
Across the street from UPMC Shadyside, connected by the Shea Pedestrian Bridge, is Hillman Cancer Center, headquarters for the research facilities of the University of Pittsburgh Cancer Institute (UPCI), which works in tandem with the clinical services of UPMC Cancer Centers.
UPCI’s research programs occupy a 152,300-square-foot, three-level research pavilion at Hillman Cancer Center; the rest of the building is devoted to clinical care for cancer patients. Thus Hillman Cancer Center is designed to maximize collaboration among investigators, to streamline the application of laboratory findings to patient care, and to facilitate the flow of information about clinical experiences back to researchers for further development.
With cutting-edge research in basic science as well as clinical trials, UPCI ranks among the nation’s leaders in funding from the National Cancer Institute (NCI).
UPCI-initiated clinical research has garnered national and international recognition for the advanced treatment of melanoma, as well as brain, prostate, lung, head and neck, ovarian, and breast cancers.
UPMC Shadyside supports research in an effort to deliver the highest quality patient care. Nursing care delivery impacts patient outcomes in multiple ways.
Our research efforts are focused on increasing efficiency while at the same time maintaining or improving high-quality outcomes.
Recent nursing research projects at UPMC Shadyside have studied:
Transforming Care at the Bedside (TCAB) initiatives have been a part of the culture at UPMC Shadyside for more than 10 years. UPMC Shadyside was one of three hospitals in the United States to pilot this approach.
Today, all inpatient nursing units participate in the TCAB philosophy, which allows for rapid tests of change in order to improve work-flow processes.
For more information about research studies at UPMC, visit the Pitt+Me Research Participant Registry.